These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2524793)

  • 21. Partial splenectomy in homozygous beta thalassaemia.
    de Montalembert M; Girot R; Revillon Y; Jan D; Adjrad L; Ardjoun FZ; Belhani M; Najean Y
    Arch Dis Child; 1990 Mar; 65(3):304-7. PubMed ID: 2334210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088
    [No Abstract]   [Full Text] [Related]  

  • 23. Splenectomy for Children With Thalassemia: Total or Partial Splenectomy, Open or Laparoscopic Splenectomy.
    Al-Salem AH
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):1-4. PubMed ID: 24577545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of partial splenectomy in children with thalassemia.
    al-Salem AH; al-Dabbous I; Bhamidibati P
    Eur J Pediatr Surg; 1998 Dec; 8(6):334-8. PubMed ID: 9926300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body growth in Cooley's anemia (homozygous beta-thalassemia) with a correlative study as to other aspects of the illness in 138 cases.
    Logothetis J; Loewenson RB; Augoustaki O; Economidou J; Constantoulakis M
    Pediatrics; 1972 Jul; 50(1):92-9. PubMed ID: 5038114
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term results of splenectomy in thalassemia major].
    Alamanni F; Gallisai D; Maniga AM; Bacciu PP; Noya G; Frassetto GA; Dettori G; Biglioli P
    Minerva Chir; 1983 May; 38(10):693-6. PubMed ID: 6877629
    [No Abstract]   [Full Text] [Related]  

  • 27. Changing patterns of splenectomy in transfusion-dependent thalassemia patients.
    Piga A; Serra M; Longo F; Forni G; Quarta G; Cappellini MD; Galanello R
    Am J Hematol; 2011 Sep; 86(9):808-10. PubMed ID: 21850661
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful full-term pregnancy in homozygous beta-thalassemia major: case report and review of the literature.
    Mordel N; Birkenfeld A; Goldfarb AN; Rachmilewitz EA
    Obstet Gynecol; 1989 May; 73(5 Pt 2):837-40. PubMed ID: 2649825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta Beta-Thalassaemia in two yugoslavian families.
    Efremov GD; Nikolov N; Duma H; Schroeder WA; Miller A; Huisman TH
    Scand J Haematol; 1975 May; 14(3):226-32. PubMed ID: 1145125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems related to treatment of beta-thalassaemia major.
    Economidou J
    Paediatrician; 1982; 11(3-4):157-77. PubMed ID: 7043374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of beta-thalassemias in a developing country. Experience of a pediatric service in Oran (Algeria)].
    Bouhass RA; Kabouya EA; Smahi C; Benaceur SM; Aguercif M
    Ann Pediatr (Paris); 1992 Feb; 39(2):115-9. PubMed ID: 1580524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [EFFECTS OF SPLENECTOMY ON STATURE AND WEIGHT INCREASE AND SKELETAL AGE IN THALASSEMICS].
    LOJACONO F; ARCARA G; BELLISA A
    Clin Pediatr (Bologna); 1963 Jul; 45():459-82. PubMed ID: 14111829
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
    Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and clinical effects of vitamin E administration in homozygous beta-thalassemia.
    Giardini O; Cantani A; Donfrancesco A; Martino F; Mannarino O; D'Eufemia P; Miano C; Ruberto U; Lubrano R
    Acta Vitaminol Enzymol; 1985; 7(1-2):55-60. PubMed ID: 4036760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme.
    Rebulla P; Modell B
    Lancet; 1991 Feb; 337(8736):277-80. PubMed ID: 1671122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dangerous outcomes of blood transfusion to thalassemia patients in Pakistan.
    Shah DA
    J Infect Public Health; 2015; 8(5):510-1. PubMed ID: 25731675
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thalassemia intermedia: 36 cases].
    Hafsia R; Ben Salah N; Hafhouf E; Belakhal F; Gouider E; El Borji W; Meddeb B
    Tunis Med; 2010 Feb; 88(2):102-4. PubMed ID: 20415168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.